共 23 条
[1]
NCCN guidelines™, Head and Neck Cancers, (2011)
[2]
Gregoire V., Lefebvre J.L., Licitra L., Felip E., Et al., Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment, and follow-up, Ann Oncol, 21, SUPPL. 5, (2010)
[3]
Kurzgefasste interdisziplinäre leitlinien, Empfehlungen Zur Diagnostik und Therapie Maligner Erkrankungen, (2008)
[4]
AWMF Leitlinie S1 Hals: Zustand Nach Tumor-OP, 11, (2009)
[5]
Al-Ibraheem A., Buck A., Krause B.J., Scheidhauer K., Schwaiger M., Clinical applications of FDG PET and PET/CT in head and neck cancer, J Oncol, 2009, (2009)
[6]
Klabbers B.M., Lammertsma A.A., Slotman B.J., The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer, Mol Imaging Biol, 5, 4, pp. 257-270, (2003)
[7]
Ryan W.R., Fee Jr. W.E., Le Q.-T., Pinto H.A., Positronemission tomography for surveillance of head and neck cancer, Laryngoscope, 115, 4, pp. 645-650, (2005)
[8]
Abgral R., Querellou S., Potard G., Et al., Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?, J Nucl Med, 50, 1, pp. 24-29, (2009)
[9]
Wang Y.-F., Liu R.-S., Chu P.-Y., Et al., Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy, Head Neck, 31, 4, pp. 442-451, (2009)
[10]
Cermik T.F., Mavi A., Acikgoz G., Houseni M., Dadparvar S., Alavi A., FDG PET in detecting primary and recurrent malignant salivary gland tumors, Clin Nucl Med, 32, 4, pp. 286-291, (2007)